Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials Read more
Low patient accrual rates cause termination of over 25 per cent rare disease trials: GlobalData Read more
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase III trial Read more
Researchers at Strathclyde University study effect of Favipiravir against mild COVID-19 infections Read more
Regulatory agencies have provided various leverages to adopt digital technologies in business operations Read more
Windlas Biotech, Mateon Therapeutics partner to launch combined lung therapy and AI telemedicine solution Read more